Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Stephenson et al find "alarmingly high rates" of intimate partner violence among male couples

Social Science One making available data that "may rival the total amount that currently exists in the social sciences"

Stafford's findings on gender gap in children's allowances suggest entrenched nature of wage gap

More News

Highlights

Student volunteers needed for IAPHS Annual Meeting in Washington, DC, Oct 3-5. Register July 23.

West et al. examine HS seniors' nonmedical use of prescription stimulants to boost study

Seefeldt promoted to associate professor of social work, associate professor of public policy

Martha Bailey elected to the Board of Officers of the Society of Labor Economists

More Highlights

Next Brown Bag

More PSC brown bags, Fall 2018

Stunting Is Characterized by Chronic Inflammation in Zimbabwean Infants

Publication Abstract

Pendergast, Andrew J., Andrew Jones, Sandra Rukobo, Bernard Chasekwa, Kuda Mutasa, Robert Ntozini, Mduduzi N. N. Mbuya, Lawrence H. Moulton, et al. 2014. "Stunting Is Characterized by Chronic Inflammation in Zimbabwean Infants." PLOS ONE, 9(2): e86928.

Background: Stunting affects one-third of children in developing countries, but the causes remain unclear. We hypothesized that enteropathy leads to low-grade inflammation, which suppresses the growth hormone-IGF axis and mediates stunting.

Methods: We conducted a case-control study of 202 HIV-unexposed Zimbabwean infants who were stunted (height-for-age Z-score (HAZ) <−2; cases) or non-stunted (HAZ >−0.5; controls) at 18 months. We measured biomarkers of intestinal damage (I-FABP), inflammation (CRP, AGP, IL-6) and growth hormone-IGF axis (IGF-1, IGFBP3) in infant plasma at 6 weeks and 3, 6, 12 and 18 months, and in paired maternal-infant plasma at birth. Adjusted mean differences between biomarkers were estimated using regression models. Multivariate odds ratios of stunting were estimated by logistic regression.

Results: At birth, cases were shorter (median (IQR) HAZ −1.00 (−1.53, −0.08) vs 0.03 (−0.57, 0.62,); P<0.001) than controls and their mothers had lower levels of IGF-1 (adjusted mean difference (95%CI) −21.4 (−39.8, −3.1) ng/mL). From 6 weeks to 12 months of age, levels of CRP and AGP were consistently higher and IGF-1 and IGFBP3 lower in cases versus controls; IGF-1 correlated inversely with inflammatory markers at all time-points. I-FABP increased between 3–12 months, indicating extensive intestinal damage during infancy, which was similar in cases and controls. In multivariate analysis, higher log10 levels of CRP (aOR 3.06 (95%CI 1.34, 6.99); P = 0.008) and AGP (aOR 7.87 (95%CI 0.74, 83.74); P = 0.087) during infancy were associated with stunting. There were no associations between levels of I-FABP, IL-6, sCD14 or EndoCAb and stunting.

Conclusions: Stunting began in utero and was associated with low maternal IGF-1 levels at birth. Inflammatory markers were higher in cases than controls from 6 weeks of age and were associated with lower levels of IGF-1 throughout infancy. Higher levels of CRP and AGP during infancy were associated with stunting. These findings suggest that an extensive enteropathy occurs during infancy and that low-grade chronic inflammation may impair infant growth.

DOI:10.1371/journal.pone.0086928 (Full Text)

PMCID: PMC3928146. (Pub Med Central)

Country of focus: Zimbabwe.

Browse | Search : All Pubs | Next